View in EDS

Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population-based modelling study.

Saved in:
Bibliographic Details
Title: Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population-based modelling study.
Authors: Himmler S; a Health Economics , WifOR , Darmstadt , Germany., Müller M; a Health Economics , WifOR , Darmstadt , Germany., Ostwald D; a Health Economics , WifOR , Darmstadt , Germany., Seddik A; a Health Economics , WifOR , Darmstadt , Germany., Basic E; b Health Technology Assessment & Outcomes Research , Pfizer Deutschland GmbH , Berlin , Germany., Hradetzky E; c Medical Affairs Internal Medicine , Pfizer Pharma GmbH , Berlin , Germany.
Source: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2019 Apr; Vol. 19 (2), pp. 223-230. Date of Electronic Publication: 2018 Oct 08.
Publication Type: Comparative Study; Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8379 (Electronic) Linking ISSN: 14737167 NLM ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30295561
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population-based modelling study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Himmler+S%22">Himmler S</searchLink>; a Health Economics , WifOR , Darmstadt , Germany.<br /><searchLink fieldCode="AU" term="%22Müller+M%22">Müller M</searchLink>; a Health Economics , WifOR , Darmstadt , Germany.<br /><searchLink fieldCode="AU" term="%22Ostwald+D%22">Ostwald D</searchLink>; a Health Economics , WifOR , Darmstadt , Germany.<br /><searchLink fieldCode="AU" term="%22Seddik+A%22">Seddik A</searchLink>; a Health Economics , WifOR , Darmstadt , Germany.<br /><searchLink fieldCode="AU" term="%22Basic+E%22">Basic E</searchLink>; b Health Technology Assessment & Outcomes Research , Pfizer Deutschland GmbH , Berlin , Germany.<br /><searchLink fieldCode="AU" term="%22Hradetzky+E%22">Hradetzky E</searchLink>; c Medical Affairs Internal Medicine , Pfizer Pharma GmbH , Berlin , Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132257%22">Expert review of pharmacoeconomics & outcomes research</searchLink> [Expert Rev Pharmacoecon Outcomes Res] 2019 Apr; Vol. 19 (2), pp. 223-230. <i>Date of Electronic Publication: </i>2018 Oct 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Comparative Study; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101132257 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8379 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214737167%22">14737167 </searchLink><i>NLM ISO Abbreviation: </i>Expert Rev Pharmacoecon Outcomes Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30295561
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14737167.2019.1522501
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 223
    Titles:
      – TitleFull: Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population-based modelling study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Himmler S
      – PersonEntity:
          Name:
            NameFull: Müller M
      – PersonEntity:
          Name:
            NameFull: Ostwald D
      – PersonEntity:
          Name:
            NameFull: Seddik A
      – PersonEntity:
          Name:
            NameFull: Basic E
      – PersonEntity:
          Name:
            NameFull: Hradetzky E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2019 Apr
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8379
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Expert review of pharmacoeconomics & outcomes research
              Type: main
ResultId 1